These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2005-000394-21 A Double-Blind Phase II Study of HDP 99.0006 in Patients with Actinic Keratosis 2006-10-26 due-trials
Completed, but no date 2005-001680-57 Phase II study of fosfluridine tidoxil in an oral multiple dose schedule given once-a-day for 7 consecutive days every 2 weeks in patients with advanced breast and colorectal cancer bad-data
Not reported 2006-001107-10 A randomized, double-blind, placebo-controlled, phase II, dose finding, multicenter study to explore the safety, tolerability, efficacy, and pharmacokinetics of fosalvudine tidoxil capsules in antiret... 2007-02-01 due-trials
Not reported 2006-005525-33 A Multi-Centre Double-Blind Randomised Placebo-Controlled Phase II Study of HDP 99.0006 in Patients with Actinic Keratosis 2008-01-09 due-trials
Exempt 2020-003414-12 A Phase 1/2a, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HDP-101 in Patients with Plasma Cell Disorders Including Multiple Myeloma not-yet-due